A novel live cell platform utilizing phenotypic biophysical and molecular biomarkers for assessing prostate cancer aggressiveness.

被引：0
|
作者：
Knopf, Kevin B.
Rieger-Christ, Kimberly M.
Sullivan, Travis B.
Kella, Naveen
Hernandez, Ray
Rashid, Hani H.
Mouraviev, Vladimir
Manak, Michael S.
Su, Wendell R.
Min, Andrew
Berger, Delaney
Hogan, Brad J.
Saphirstein, Robert J.
Whitfield, Matt J.
Varsanik, Jonathan S.
Foroohar, Mani
Albala, David
Chander, Ashok C.
Sant, Grannum R.
机构：
[1] Calif Pacific Med Ctr, San Francisco, CA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
[3] Urol & Prostate Inst, San Antonio, TX USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[5] Associated Med Profess New York PLLC, Syracuse, NY USA
[6] Cellanyx Diagnost, Beverly, MA USA
[7] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A novel live cell platform diagnostic utilizing phenotypic biomarkers for assessing prostate cancer aggressiveness.
    Knope, Kevin B.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Rashid, Hani H.
    Mouraviev, Vladimir
    Manak, Michael S.
    Hogan, Brad J.
    Dixlt, Gauri
    Su, Wendell R.
    Berger, Delaney
    Whitfield, Matthew J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Zappala, Stephen M.
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer.
    Albala, David
    Mouraviev, Vladimir
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Knopf, Kevin B.
    Rashid, Hani H.
    Manak, Michael S.
    Hogan, Brad J.
    Dixit, Gauri
    Berger, Delaney
    Su, Wendell R.
    Whitfield, Matthew J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Zappala, Stephen M.
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [3] Novel live tumor cell diagnostic test utilizing biophysical and molecular biomarkers to assess local, advanced, and metastatic prostate cancer.
    Knopf, Kevin B.
    Manak, Michael S.
    Su, Wendell R.
    Meyyappan, Thiagarajan
    Min, Andrew
    Saphirstein, Robert J.
    Hogan, Brad J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Kella, Naveen
    Hernandez, Ray
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Rashid, Hani H.
    Mouraviev, Vladimir
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] Live cell in vitro prognostic utilizing biophysical and molecular biomarkers for measuring local growth and metastatic potential in prostate cancer
    Chander, Ashok C.
    Manak, Michael S.
    Ramu, Senthil K.
    Su, Wendell R.
    Meyyappan, Thiagu
    Hogan, Brad J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Microarray-based molecular diagnostics: An application to predicting prostate cancer aggressiveness.
    Moraleda, J
    Buturovic, L
    Tran, Q
    Pattin, A
    Anderson, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 872S - 872S
  • [6] Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
    Giskeodegard, Guro F.
    Bertilsson, Helena
    Selnaes, Kirsten M.
    Wright, Alan J.
    Bathen, Tone F.
    Viset, Trond
    Halgunset, Jostein
    Angelsen, Anders
    Gribbestad, Ingrid S.
    Tessem, May-Britt
    [J]. PLOS ONE, 2013, 8 (04):
  • [7] A NOVEL LIVE CELL MICROFLUIDIC DIAGNOSTIC USING PHENOTYPIC BIOMARKERS WITH OBJECTIVE ALGORITHMIC ANALYSIS FOR PROSTATE CANCER RISK STRATIFICATION.
    Rieger-Christ, Kimberly
    Sullivan, Travis
    Kella, Naveen
    Hernandez, Ray
    Mouraviev, Vladimir
    Knopf, Kevin
    Rashid, Hani
    Manak, Michael
    Su, Wendell
    Hogan, Brad
    Min, Andrew
    Berger, Delaney
    Whitfield, Matthew
    Varsanik, Jonathan
    Foroohar, Mani
    Chander, Ashok
    Albala, David
    Sant, Grannum
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E8 - E9
  • [8] A novel live cell diagnostic platform measuring phenotypic biomarkers using objective algorithmic analysis enables further risk stratification for intermediate-risk prostate cancer patients
    Manak, Michael S.
    Su, Wendell R.
    Min, Andrew
    Hogan, Brad J.
    Whitfield, Matthew J.
    Varsanik, Jonathan S.
    Bergen, Delaney
    Foroohar, Mani
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Hernandez, Ray
    Mouraviev, Vladimir
    Knopf, Kevin B.
    Rashid, Hani H.
    Albala, David M.
    Sant, Grannum R.
    Chander, Ashok C.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] A novel live cell microfluidic diagnostic using phenotypic biomarkers with objective algorithmic analysis for genitourinary cancer risk stratification
    Sant, G.
    Rieger-Christ, K.
    Kella, N.
    Mouraviev, V.
    Knopf, K. B.
    Rashid, H. H.
    Manak, M. S.
    Hogan, B. J.
    Varsanik, J. S.
    Foroohar, M.
    Chander, A. C.
    Albala, D. M.
    [J]. BJU INTERNATIONAL, 2016, 117 : 4 - 4
  • [10] Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
    Grannum R. Sant
    Kevin B. Knopf
    David M. Albala
    [J]. npj Precision Oncology, 1
12345